PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer
Gilles Rademaker(University of Liège), Rushika M. Perera(University of California, San Francisco)
Cited by 30
Related Papers
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
|Nature|2015|788
Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity
|Clinical Cancer Research|2005|103